Cerence’s fiscal fourth-quarter report carries added significance as it wraps up a transitional year. In the fiscal third quarter, reported on August 6, 2026, revenue increased 12% year over year to roughly $69.6 million, though EPS of $0.03 fell short of expectations partly due to higher intellectual-property legal costs. Management described the upcoming quarter as a typical seasonal decline rather than any indication of softening demand. I’m watching closely to see whether recurring connected-services growth and the commercial rollout of the generative-AI product xUI can provide support as the company moves into the next fiscal year. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the fiscal fourth quarter of 2026, the company guided to revenue of $61 million to $65 million, gross margin of 72% to 73%, adjusted EBITDA of $1 million to $5 million, and diluted EPS of $0.02 to $0.10. Management noted that no fixed-license revenue is expected, which tends to pressure both the top line and margins. Consensus estimates point to revenue of about $63.8 million and EPS of roughly $0.17, with the difference between guidance and consensus partly reflecting variations in adjusted versus GAAP treatment. Key metrics to monitor include connected-services revenue, free cash flow, and any updates on xUI adoption and design wins. For the full fiscal 2026 year, prior guidance called for revenue of $310 million to $314 million, adjusted EBITDA of $66 million to $70 million, and free cash flow of $76 million to $82 million.
Sentiment ahead of the report appears measured rather than overly defensive. CRNC shares have shown volatility around recent earnings releases, with sizable post-announcement moves in the past. The primary risk lies in the expected lack of fixed-license revenue, which could make reported revenue appear weaker even if recurring streams remain steady. Another area of focus is forward guidance, given that fiscal 2027 visibility is still developing. Investors will look for signs of durable growth in connected services and xUI or whether management maintains a cautious tone. A stronger-than-expected outlook could influence the stock more than the quarter’s results themselves.
The most significant element of this release is likely the first official guidance for fiscal 2027. Management has positioned the year as one of growth driven by xUI, connected services, and expansion beyond automotive. From what I see, investors should look for concrete revenue and margin targets to back up that view. Several operational factors will shape the outlook. Connected-services momentum remains important, as recurring revenue rose 20% year over year last quarter and continued expansion would improve visibility. Progress on xUI commercialization, including roughly 100,000 cars shipped and new design wins with a global premium automaker, will also be relevant. In addition, the cost base deserves attention given the elevated intellectual-property legal spending that affected profitability in the prior quarter. Balance-sheet and capital-return signals matter as well. Cerence ended its fiscal third quarter with about $128 million in cash and announced a new $30 million share repurchase program. Updates on free cash flow generation and any further buyback activity will be closely watched. While no single metric will define the quarter, the combination of forward guidance, recurring-revenue trends, and cash discipline should set the tone for how investors interpret the results.
In my analysis of names like CRNC, I often turn to Tickeron’s AI Screener to quickly filter for technical patterns, fundamentals, and AI-driven signals across thousands of stocks and ETFs. It helps me build watchlists more efficiently by applying customizable criteria such as industry, market cap, volatility, and performance metrics. This approach has become a regular part of how I prepare for earnings seasons and identify comparable opportunities.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CRNC declined for three days, in 302 of 343 cases, the price declined further within the following month. The odds of a continued downward trend are 88%.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRNC as a result. In 71 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for CRNC turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 41 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
CRNC moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CRNC crossed bearishly below the 50-day moving average on November 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.
The Aroon Indicator for CRNC entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for CRNC's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +7.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRNC advanced for three days, in 199 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
CRNC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.216) is normal, around the industry mean (-1.922). P/E Ratio (-22.639) is within average values for comparable stocks, (9.599). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (1.132) is also within normal values, averaging (70.699).
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. CRNC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRNC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company, which builds automotive cognitive assistance solutions to power natural and intuitive interactions between automobiles, drivers and passengers, and the broader digital world
Industry PackagedSoftware